Doing Real World Evidence Studies in addition to clinical trials is key for achieving a successful market access.

Written By Thomas Wilke

But where to find the necessary data, specifically in oncology? Do specific research objectives require specific datasets?

Using Germany as an example, GIPAM’s Scientific Lead, Prof. Dr. Thomas Wilke, outlines in this video which oncology datasets are available in Germany.

And indeed: he confirms that the main research question decides whether claims data, cancer registry data, existing EMR data or data collection in a MCR or prospective study are the method of choice for a study.

Watch the full conversation here:

https://www.youtube.com/watch?v=H6Bhme7uSj0

For further inquiries please contact us:
Thomas Wilke
info@gipam-health.com

Thomas Wilke
Next

Behind the Tech: How We're Automating Systematic Literature Reviews